Yablonski M E, Shin D H, Kolker A E, Kass M, Becker B
Arch Ophthalmol. 1977 Dec;95(12):2157-8. doi: 10.1001/archopht.1977.04450120063004.
Twelve patients who had previously demonstrated an intolerance to topically applied epinephrine received dipivefrin 0.1% in one eye and epinephrine 2% in the other eye. An adverse reaction occurred in only one eye (8%) receiving dipivefrin, but in ten (83%) on epinephrine. Topical dipivefrin 0.1% proved useful for lowering intraocular pressure in patients intolerant to topically applied epinephrine.
12名先前已证明对局部应用肾上腺素不耐受的患者,一只眼睛使用0.1%的双特戊肾上腺素,另一只眼睛使用2%的肾上腺素。不良反应仅发生在一只(8%)使用双特戊肾上腺素的眼睛,但在10只(83%)使用肾上腺素的眼睛中出现。0.1%的局部用双特戊肾上腺素被证明对不耐受局部应用肾上腺素的患者降低眼压有效。